摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-[3-(furan-3-yl)-3-oxoprop-1-yl]-5-(triisopropylsilyloxy)benzocyclobutene-1-carbonitrile ethylene ketal | 917967-37-4

中文名称
——
中文别名
——
英文名称
1-[3-(furan-3-yl)-3-oxoprop-1-yl]-5-(triisopropylsilyloxy)benzocyclobutene-1-carbonitrile ethylene ketal
英文别名
7-[2-[2-(Furan-3-yl)-1,3-dioxolan-2-yl]ethyl]-4-tri(propan-2-yl)silyloxybicyclo[4.2.0]octa-1(6),2,4-triene-7-carbonitrile;7-[2-[2-(furan-3-yl)-1,3-dioxolan-2-yl]ethyl]-4-tri(propan-2-yl)silyloxybicyclo[4.2.0]octa-1(6),2,4-triene-7-carbonitrile
1-[3-(furan-3-yl)-3-oxoprop-1-yl]-5-(triisopropylsilyloxy)benzocyclobutene-1-carbonitrile ethylene ketal化学式
CAS
917967-37-4
化学式
C27H37NO4Si
mdl
——
分子量
467.681
InChiKey
XQCQEKWQWPSTRK-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    6.83
  • 重原子数:
    33
  • 可旋转键数:
    9
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.59
  • 拓扑面积:
    64.6
  • 氢给体数:
    0
  • 氢受体数:
    5

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    1-[3-(furan-3-yl)-3-oxoprop-1-yl]-5-(triisopropylsilyloxy)benzocyclobutene-1-carbonitrile ethylene ketal邻二氯苯 为溶剂, 反应 2.0h, 以59%的产率得到2,3,5a,10c-tetrahydro-1H,6H-5-oxa-3-oxo-9-(triisopropylsilyloxy)acephenanthrylene-10b-carbonitrile ethylene ketal
    参考文献:
    名称:
    Synthesis and biological evaluation of dihydrofuran-fused perhydrophenanthrenes as a new anti-influenza agent having novel structural characteristic
    摘要:
    Dihydrofuran-fused perhydrophenanthrenes were synthesized by means of o-quinodimethane chemistry with high generality and stereoselectivity, and found to exhibit potent anti-influenza activity. These compounds exerted an inhibitory effect on various strains of influenza virus growth, including influenza A and B, with a concentration dependent manner, and direct cytotoxicity was low. Several biological experiments suggested that these new drugs affected a virus replication process before mRNA synthesis stage. Novel rigid cage-type of structural characteristic of the compounds has not been found in hitherto anti-influenza drugs, and will provide new basis and motif for exploring promising and unprecedented anti-influenza agents. (c) 2006 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmc.2006.09.046
  • 作为产物:
    参考文献:
    名称:
    Synthesis and biological evaluation of dihydrofuran-fused perhydrophenanthrenes as a new anti-influenza agent having novel structural characteristic
    摘要:
    Dihydrofuran-fused perhydrophenanthrenes were synthesized by means of o-quinodimethane chemistry with high generality and stereoselectivity, and found to exhibit potent anti-influenza activity. These compounds exerted an inhibitory effect on various strains of influenza virus growth, including influenza A and B, with a concentration dependent manner, and direct cytotoxicity was low. Several biological experiments suggested that these new drugs affected a virus replication process before mRNA synthesis stage. Novel rigid cage-type of structural characteristic of the compounds has not been found in hitherto anti-influenza drugs, and will provide new basis and motif for exploring promising and unprecedented anti-influenza agents. (c) 2006 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmc.2006.09.046
点击查看最新优质反应信息

文献信息

  • Synthesis and biological evaluation of dihydrofuran-fused perhydrophenanthrenes as a new anti-influenza agent having novel structural characteristic
    作者:Yuji Matsuya、Kazushige Sasaki、Hiroshi Ochiai、Hideo Nemoto
    DOI:10.1016/j.bmc.2006.09.046
    日期:2007.1.1
    Dihydrofuran-fused perhydrophenanthrenes were synthesized by means of o-quinodimethane chemistry with high generality and stereoselectivity, and found to exhibit potent anti-influenza activity. These compounds exerted an inhibitory effect on various strains of influenza virus growth, including influenza A and B, with a concentration dependent manner, and direct cytotoxicity was low. Several biological experiments suggested that these new drugs affected a virus replication process before mRNA synthesis stage. Novel rigid cage-type of structural characteristic of the compounds has not been found in hitherto anti-influenza drugs, and will provide new basis and motif for exploring promising and unprecedented anti-influenza agents. (c) 2006 Elsevier Ltd. All rights reserved.
查看更多